Differences in survival between colon and rectal cancer from SEER data.
about
Adjuvant chemotherapy for rectal cancer: Is it needed?Tumor location as a novel high risk parameter for stage II colorectal cancers.Pattern of distant metastases in colorectal cancer: a SEER based study.Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response.Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012.Site-specific associations between miRNA expression and survival in colorectal cancer cases.Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and affects cell proliferation by epigenetically silencing of p15Combinatorial nanomedicines for colon cancer therapy.Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles.The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.Determinants of healthcare utilisation and predictors of outcome in colorectal cancer patients from Northern Iran.Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.Chronic hepatitis C infection as a risk factor for renal cell carcinoma.RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival.Ca2+/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation.MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.Laparoscopic vs. open surgery for T4 colon cancer: A propensity score analysis.Water-enema multidetector computed tomography for planning surgery.Distinctive features of gastrointestinal stromal tumors arising from the colon and rectum.Different Anatomical Subsites of Colon Cancer and Mortality: A Population-Based StudyOverexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
P2860
Q26775099-74F2359C-D023-4D57-A91E-87432B605CCCQ33828917-667BF07B-83FF-44DB-8D53-E16AB70887ABQ34674089-2A357CAB-EDA5-4F71-9595-7B2E133B37F9Q36118410-24FFB720-9721-4B61-8B73-6575D4A40BFBQ36216185-91FC99BB-4333-4D8E-8E2A-E49E252F6250Q37606635-93B08DEE-CE7F-407A-BFB4-CAE42810A812Q37619811-C9A1A15F-E99D-4238-AD8D-E2F0AAB8AF45Q37645004-C1A21AFF-11C8-46FC-81C6-0D97876CC312Q37745577-BCF249F3-7121-47D8-8272-ADBD2946D202Q38523659-E1014CF2-99C7-48A4-8671-76C4CEC7EF0AQ39041183-9D8538A8-643E-4DB3-AB56-329A82E53E0AQ39238657-05B84D74-7CAA-4656-A6DB-BF44FBA6981CQ40265791-B7D14226-7858-44F4-B92F-62C27455C07CQ41367522-7A69E0FC-357C-48B7-879D-5ACEEFEF2EA6Q41542344-FF360CA7-CC8B-4D6B-8CE5-9943EFB68F5CQ42873640-6B325045-2644-457C-B6A9-068AF63BD5BAQ47170227-C2D6E96C-D251-4751-B1AD-8B1CF701696BQ47347919-C5FF98A1-EC64-4B31-B4E8-7A626BA2C739Q47620298-069459C9-6F33-45A3-B50E-818DE919E64DQ48310742-8DD070A8-8D4E-410D-BB02-0400522E39DAQ50673731-DDEC1E7A-1B64-4148-A4E3-B58AFF626FECQ51020379-C7490ACE-F28F-4C75-973D-24ED8098B34CQ51810449-77FE4F16-DFF6-4F54-92F3-28E7D04BCAE7Q53024549-0D039069-25BF-489B-9344-583F68B3D736Q55032185-04C442B8-C6A5-4CF3-BE5B-93F13A376835Q57166687-20DB927B-BA19-46DA-B62F-082555E5FE06Q58768424-F0CD947E-D755-4973-9AD1-BEED79F28D35
P2860
Differences in survival between colon and rectal cancer from SEER data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Differences in survival between colon and rectal cancer from SEER data.
@ast
Differences in survival between colon and rectal cancer from SEER data.
@en
type
label
Differences in survival between colon and rectal cancer from SEER data.
@ast
Differences in survival between colon and rectal cancer from SEER data.
@en
prefLabel
Differences in survival between colon and rectal cancer from SEER data.
@ast
Differences in survival between colon and rectal cancer from SEER data.
@en
P2093
P2860
P1433
P1476
Differences in survival between colon and rectal cancer from SEER data.
@en
P2093
Jen-Pin Chuang
Jenq-Chang Lee
Yen-Chien Lee
Yen-Lin Lee
P2860
P304
P356
10.1371/JOURNAL.PONE.0078709
P407
P577
2013-11-12T00:00:00Z